LTRN 3.14 (-2.18%)
US51654W1018BiotechnologyBiotechnology

Lantern Pharma (LTRN) Stock Highlights

3.14 | -2.18%
2024-12-21 07:20:04
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firms pipeline of development programs involves four drug candidates and an Antibody Drug Conjugate (ADC) program directed towards eight therapeutic targets. Its A.I. platform, known as RADR, includes more than 18 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds.

Statistics

Range Today
3.1 3.41
Volume Today 38.6K
Range 1 Year
2.79 11.99
Volume 1 Year 31.56M
Range 3 Year
2.38 11.99
Volume 3 Year 51.92M
Range 10 Year
2.38 24.84
Volume 10 Year 86.75M

Highlights

Market Capitalization 41.34M (micro)
Floating Shares 7.94M
Current Price 3.14
Price To Earnings -1.82
Price To Book 1.01
Earnings Per Share -1.85
Payout Ratio 0%

Performance

Latest -2.18%
1 Month +4.67%
3 Months -21.11%
6 Months -31.89%
1 Year -24.15%
3 Years -57.97%
5 Years -78.78%
10 Years -78.78%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.